Protein deep sequencing applied to biobank samples from patients with pancreatic cancer.
Research output: Contribution to journal › Article
Pancreatic cancer is commonly detected at advanced stages when the tumor is no longer amenable to surgical resection. Therefore, finding biomarkers for early stage disease is urgent. Here, we show that high-definition mass spectrometry (HDMS(E)) can be used to identify serum protein alterations associated with early stage pancreatic cancer.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Journal||Journal of Cancer Research and Clinical Oncology|
|Publication status||Published - 2015|